… HPV subunit vaccine protects women from a high proportion of precursor lesions of cervical
… examine the ramifications and remaining questions that surround preventive HPV vaccines. …

… Further, to exclude possible prevalent cervical cancers at the date of HPV vaccination, we
used a buffer period of 1 to 5 years at 1-year intervals after the index date of HPV vaccination (…

… tested (see nine-valent vaccines), a pan-HPV vaccine that could be easily and … cervical
cancer screening interventions. Indeed, these have to remain in place with the current vaccine …

… 4 , but the incidences of these cancers and the fractions that are attributable to HPV
infection are lower, and so HPV vaccines have principally been used to target cervical cancer. …

… This expansion has been greatly aided by funding from the Gates Foundation and an
overall reinvigorated interest in vaccines. To deliver an HPV vaccine for cervical cancer to the …

… HPV vaccination will protect against cervical cancer. Trials have not focused on the outcome
of cervical cancer … them up for long enough: cervical cancer may take decades to develop. …

… This review aims to offer the reader a complete and updated overview on the HPV vaccination.
The … HPV vaccines, and highlight the main characteristics of the new generation vaccines. …

… impact of HPV vaccines and … HPV infections and progression to cervical cancer. As described
in Chapter 5, the risks of progression and regression through stages of neoplasia to cancer …

… HPV vaccines do not eliminate the risk of cervical cancer, cervical screening will still be
required to minimize cancer … of key information on HPV and HPV vaccines for policy-makers. It is …

… might be prevented or treated by HPV vaccines. Two … breast cancer deaths by no more
than one third. By comparison, an HPV vaccine that successfully targeted all cervical cancer …